![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Hepatitis |
Free Subscription
1 Am J Gastroenterol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Hepatitis is free of charge.
Personalized Antiviral Drug Selection in Chronic Hepatitis B Patients Using a
Machine Learning Model: A Multinational Study.
Am J Gastroenterol. 2023 Mar 7. doi: 10.14309/ajg.0000000000002234.
PubMed
Abstract available
Hepatitis C virus reinfection in a real-world cohort of homeless-experienced
individuals in Boston.
Clin Infect Dis. 2023 Mar 4:ciad127. doi: 10.1093.
PubMed
Abstract available
Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the
REVEAL-HBV and REVEAL-HCV Cohort Studies.
Int J Cancer. 2023 Mar 6. doi: 10.1002/ijc.34492.
PubMed
Abstract available
Deregulated intracellular pathways define novel molecular targets for
HBV-specific CD8 T cell reconstitution in chronic hepatitis B.
J Hepatol. 2023 Mar 7:S0168-8278(23)00167-8. doi: 10.1016/j.jhep.2023.
PubMed
Abstract available
Primary sclerosing cholangitis and overlap features of autoimmune hepatitis: a
coming of age or an age-ist problem?
J Hepatol. 2023 Mar 2:S0168-8278(23)00162-9. doi: 10.1016/j.jhep.2023.
PubMed
Abstract available
HERV1-env Induces Unfolded Protein Response Activation in Autoimmune Liver
Disease: A Potential Mechanism for Regulatory T Cell Dysfunction.
J Immunol. 2023 Feb 1:ji2100186. doi: 10.4049/jimmunol.2100186.
PubMed
Abstract available
Use of whole genome sequencing to estimate the contribution of immune evasion and
waning immunity on decreasing COVID-19 vaccine effectiveness.
J Infect Dis. 2022 Nov 21:jiac453. doi: 10.1093.
PubMed
Abstract available
Hepatitis B Virus (HBV) Upregulates TRAIL-R3 Expression in Hepatocytes Resulting
in Escape From Both Cell Apoptosis and Suppression of HBV Replication by TRAIL.
J Infect Dis. 2023;227:686-695.
PubMed
Abstract available
Is nonalcoholic fatty liver disease a predictor of treatment response in chronic
hepatitis B?
J Med Virol. 2023 Mar 10. doi: 10.1002/jmv.28654.
PubMed
Abstract available
Safety and efficacy of double plasma molecular adsorption system with sequential
low-volume plasma exchange in intermediate-stage hepatitis B virus-related
acute-on-chronic liver failure.
J Med Virol. 2023 Mar 10. doi: 10.1002/jmv.28650.
PubMed
Abstract available
KIR2DL4/HLA-G polymorphisms were associated with HCV infection susceptibility
among Chinese high-risk population.
J Med Virol. 2023 Mar 8. doi: 10.1002/jmv.28645.
PubMed
Abstract available
Improved Hepatitis Delta Virus genome characterization by single molecule
full-length genome sequencing combined with VIRiONT pipeline.
J Med Virol. 2023 Mar 6. doi: 10.1002/jmv.28634.
PubMed
Abstract available
Poor glycemic control in type-2 diabetic patients infected with hepatitis B: a
retrospective propensity-matched study.
J Med Virol. 2023 Mar 4. doi: 10.1002/jmv.28635.
PubMed
Abstract available
Maintaining Hepatitis B Protection in Immunocompromised Pediatric Rheumatology
and Inflammatory Bowel Disease Patients.
J Rheumatol. 2021;48:1314-1321.
PubMed
Abstract available
Cost-effectiveness and economic investment to eliminate chronic hepatitis C in
Mexico.
J Viral Hepat. 2023 Mar 8. doi: 10.1111/jvh.13828.
PubMed
Abstract available
Comparison of acknowledged hepatocellular carcinoma risk scores in high risk
hepatitis C patients with sustained virologic response.
J Viral Hepat. 2023 Mar 8. doi: 10.1111/jvh.13829.
PubMed
Abstract available
Dynamic Personalized Prediction of the Individual Liver-Related Risk after
Sustained Viral Response in HCV patients.
J Viral Hepat. 2023 Mar 9. doi: 10.1111/jvh.13830.
PubMed
Abstract available
Impact of hepatitis C treatment status on risk of Parkinson's disease and
secondary parkinsonism in the era of direct-acting antivirals.
J Viral Hepat. 2023 Mar 5. doi: 10.1111/jvh.13826.
PubMed
Abstract available
Sera of Individuals Chronically Infected with Hepatitis B Virus (HBV) Contain
Diverse RNA Types Produced by HBV Replication or Derived from Integrated HBV DNA.
J Virol. 2023 Mar 6:e0195022. doi: 10.1128/jvi.01950.
PubMed
Abstract available
Former NIH Director Francis S. Collins on the New White House Plan to Eliminate
Hepatitis C.
JAMA. 2023 Mar 9. doi: 10.1001/jama.2023.3942.
PubMed
A National Hepatitis C Elimination Program in the United States: A Historic
Opportunity.
JAMA. 2023 Mar 9. doi: 10.1001/jama.2023.3692.
PubMed
Universal Adult Hepatitis B Screening and Vaccination as the Path to Elimination.
JAMA. 2023 Mar 10. doi: 10.1001/jama.2023.2806.
PubMed
Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations -
United States, 2023.
MMWR Recomm Rep. 2023;72:1-25.
PubMed
Abstract available
Directly observed therapy at opioid substitution facilities using
sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for
non-adherence to DAA therapy.
PLoS One. 2021;16:e0252274.
PubMed
Abstract available
A hepatitis B virus causes chronic infections in equids worldwide.
Proc Natl Acad Sci U S A. 2021;118:e2013982118.
PubMed
Abstract available
Hexavalent vaccines: What can we learn from head-to-head studies?
Vaccine. 2021;39:6025-6036.
PubMed
Abstract available
Safety of concomitant administration of inactivated hepatitis A vaccine with
other vaccines in children under 16 years old in post-marketing surveillance.
Vaccine. 2023 Mar 3:S0264-410X(23)00226-8. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by